The APD system has been designed to secure two-way connectivity, helping healthcare providers to increase visibility to monitor their patients’ home peritoneal dialysis treatments and adjust prescriptions as per requirements.

Baxter renal therapeutic area lead and vice-president Dr Bruce Culleton said: ”Claria builds upon our market-leading Homechoice APD device with new features to make the system more intuitive for patients to operate in their home and while traveling.

”Additionally, Sharesource, the system’s web-based platform, provides physicians remote access to their home patients’ treatment information allowing for more timely and personalized care.”

The system will save clinics time and enhance healthcare practice efficiencies by reducing manual input of data and gathering both patient and clinic data into organized patient report dashboards that can be easily accessed and viewed by healthcare providers.

It will also feature a large and two-line display screen that provides better visibility and a universal interface that is available in 41 languages.

Baxter renal business president Jill Schaaf said: ”Homechoice Claria with Sharesource represents Baxter’s continued commitment to advancing renal technology that offers healthcare providers and patients therapy options for end-stage renal disease.”

The company plans to start marketing the system in select European and Asian countries in the first half of this year.

Image: Baxter completes CE marking for Homechoice Claria APD system with the Sharesource web-based platform. Photo: courtesy of 2015 Baxter.